2,646 UnitedHealth Group Incorporated $UNH Shares Acquired by BDF Gestion

BDF Gestion boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 18.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 17,089 shares of the healthcare conglomerate’s stock after acquiring an additional 2,646 shares during the period. UnitedHealth Group accounts for about 0.9% of BDF Gestion’s holdings, making the stock its 21st biggest position. BDF Gestion’s holdings in UnitedHealth Group were worth $6,273,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Corient Private Wealth LP acquired a new stake in UnitedHealth Group in the 2nd quarter valued at $245,516,000. Legal & General Group Plc bought a new stake in UnitedHealth Group during the 2nd quarter valued at $2,444,928,000. Jupiter Topco LLC acquired a new position in UnitedHealth Group during the second quarter worth $2,019,844,000. BlackRock Inc. lifted its stake in shares of UnitedHealth Group by 4.6% in the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after buying an additional 3,395,530 shares in the last quarter. Finally, Canada Pension Plan Investment Board bought a new position in shares of UnitedHealth Group in the second quarter valued at $971,757,000. Institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.19% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock traded up $1.40 during trading on Monday, hitting $402.83. The company’s stock had a trading volume of 1,973,866 shares, compared to its average volume of 7,370,541. The company has a market cap of $361.58 billion, a PE ratio of 23.00, a P/E/G ratio of 1.45 and a beta of 0.60. The company has a current ratio of 0.74, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The business has a fifty day moving average of $387.07 and a 200-day moving average of $385.50. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, topping the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The business had revenue of $112.70 billion for the quarter, compared to analysts’ expectations of $111.31 billion. During the same quarter in the previous year, the firm earned $2.59 earnings per share. The business’s revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 20.64 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were issued a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date was Monday, September 14th. UnitedHealth Group’s dividend payout ratio (DPR) is 53.00%.

Analyst Ratings Changes

UNH has been the subject of several recent research reports. Bank of America reissued a “buy” rating and set a $450.00 target price on shares of UnitedHealth Group in a research report on Monday, July 20th. Morgan Stanley raised their price target on shares of UnitedHealth Group from $468.00 to $529.00 and gave the company an “overweight” rating in a research report on Friday, July 17th. Piper Sandler lifted their price target on UnitedHealth Group from $502.00 to $504.00 and gave the company an “overweight” rating in a research note on Wednesday, October 14th. DA Davidson set a $512.00 price objective on shares of UnitedHealth Group in a report on Tuesday, July 21st. Finally, Truist Financial upped their target price on shares of UnitedHealth Group from $440.00 to $480.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Twenty research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $462.90.

UnitedHealth Group Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.